International Patent: USE OF LANTHANUM OXYHYDROXIDE IN PREPARATION OF DRUG FOR TREATING HYPERPHOSPHATEMIA OR DISEASE ASSOCIATED WITH HYPERPHOSPHATEMIA

GENEVA, Aug. 31 -- BEIJING HORICIN BIOTECHNOLOGY CO., LTD. filed a patent application (CN2025/133054) for “USE OF LANTHANUM OXYHYDROXIDE IN PREPARATION OF DRUG FOR TREATING HYPERPHOSPHATEMIA OR DISEASE ASSOCIATED WITH HYPERPHOSPHATEMIA”. With publication no. WO/2026/174838, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 33/244

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....